Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDMD NASDAQ:EMBC NASDAQ:LUCD NASDAQ:PDEX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.28$1.68$0.76▼$7.26$52.45M-1.22113,031 shs96,584 shsEMBCEmbecta$3.31-0.9%$6.11$2.77▼$15.55$198.15M0.832.20 million shs1.88 million shsLUCDLucid Diagnostics$0.99+3.3%$1.10$0.90▼$1.63$194.56M1.08966,338 shs1.09 million shsPDEXPro-Dex$65.00$56.80$23.47▼$68.99$207.53M-0.0241,381 shs75,433 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment0.00%-4.48%-26.86%-50.39%-72.71%EMBCEmbecta-0.90%-5.16%-9.07%-63.22%-66.60%LUCDLucid Diagnostics+3.28%-3.93%-3.93%-31.76%-23.88%PDEXPro-Dex0.00%-2.62%+9.67%+42.33%+57.58%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.28$1.68$0.76▼$7.26$52.45M-1.22113,031 shs96,584 shsEMBCEmbecta$3.31-0.9%$6.11$2.77▼$15.55$198.15M0.832.20 million shs1.88 million shsLUCDLucid Diagnostics$0.99+3.3%$1.10$0.90▼$1.63$194.56M1.08966,338 shs1.09 million shsPDEXPro-Dex$65.00$56.80$23.47▼$68.99$207.53M-0.0241,381 shs75,433 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment0.00%-4.48%-26.86%-50.39%-72.71%EMBCEmbecta-0.90%-5.16%-9.07%-63.22%-66.60%LUCDLucid Diagnostics+3.28%-3.93%-3.93%-31.76%-23.88%PDEXPro-Dex0.00%-2.62%+9.67%+42.33%+57.58%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDMDBaird Medical Investment 1.00SellN/AN/AEMBCEmbecta 1.40Strong Sell$11.00232.33% UpsideLUCDLucid Diagnostics 2.60Moderate Buy$4.19323.19% UpsidePDEXPro-Dex 2.33Hold$70.007.69% UpsideCurrent Analyst Ratings BreakdownLatest BDMD, PDEX, LUCD, and EMBC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/8/2026LUCDLucid Diagnostics Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$9.00 ➝ $9.255/19/2026PDEXPro-Dex Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/18/2026EMBCEmbecta Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetUnderperform$11.00 ➝ $3.005/15/2026LUCDLucid Diagnostics Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$3.00 ➝ $2.005/15/2026LUCDLucid Diagnostics BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.505/12/2026PDEXPro-Dex Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$56.00 ➝ $70.005/8/2026BDMDBaird Medical Investment Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)5/8/2026EMBCEmbecta Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/6/2026EMBCEmbecta Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/6/2026LUCDLucid Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/6/2026EMBCEmbecta MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$12.00 ➝ $5.00(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDMDBaird Medical Investment$22.54M2.33N/AN/AN/A∞EMBCEmbecta$1.08B0.18$3.99 per share0.83($11.12) per share-0.30LUCDLucid Diagnostics$4.71M42.66N/AN/A($0.31) per share-3.19PDEXPro-Dex$66.59M3.11$3.14 per share20.73$11.23 per share5.79Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/AN/AEMBCEmbecta$95.40M$1.901.741.89N/A10.73%-23.96%14.12%8/6/2026 (Estimated)LUCDLucid Diagnostics-$58.01M-$0.47N/AN/AN/A-876.72%N/A-116.26%8/12/2026 (Estimated)PDEXPro-Dex$8.98M$3.6217.9623.38N/A16.08%22.78%14.30%7/8/2026 (Estimated)Latest BDMD, PDEX, LUCD, and EMBC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026LUCDLucid Diagnostics-$0.05-$0.07-$0.02-$0.17$1.38 million$1.26 million5/5/2026Q2 2026EMBCEmbecta$0.42$0.27-$0.15-$0.07$235.67 million$221.80 million4/30/2026Q3 2026PDEXPro-Dex$0.62$1.20+$0.58$1.20$17.90 million$19.95 million3/25/2026Q4 2025LUCDLucid Diagnostics-$0.07-$0.10-$0.03-$0.12$1.39 million$1.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AEMBCEmbecta$0.041.21%N/A2.11%N/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/ALatest BDMD, PDEX, LUCD, and EMBC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2026EMBCEmbectaquarterly$0.011.2%5/28/20265/28/20266/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDMDBaird Medical InvestmentN/AN/AN/AEMBCEmbectaN/A2.461.68LUCDLucid DiagnosticsN/A1.071.05PDEXPro-Dex0.323.672.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDMDBaird Medical Investment19.78%EMBCEmbecta93.83%LUCDLucid Diagnostics74.01%PDEXPro-Dex15.28%Insider OwnershipCompanyInsider OwnershipBDMDBaird Medical Investment78.90%EMBCEmbecta1.30%LUCDLucid Diagnostics6.80%PDEXPro-Dex45.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDMDBaird Medical InvestmentN/A40.98 million8.65 millionN/AEMBCEmbecta1,85059.33 million58.56 millionOptionableLUCDLucid Diagnostics70203.07 million189.26 millionNo DataPDEXPro-Dex1403.19 million1.73 millionNot OptionableBDMD, PDEX, LUCD, and EMBC HeadlinesRecent News About These CompaniesPro-Dex’s (PDEX) Acquisition Costs Now, Gains in FutureJune 3, 2026 | insidermonkey.comPro-Dex (NASDAQ:PDEX) Shares Cross Above 200-Day Moving Average - Here's WhyJune 3, 2026 | americanbankingnews.comInsider Selling: Pro-Dex (NASDAQ:PDEX) CEO Sells 4,128 Shares of StockMay 27, 2026 | insidertrades.comPro-Dex Insider Trading Activity | NASDAQ:PDEX | BenzingaMay 22, 2026 | benzinga.comPro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month ResultsApril 30, 2026 | accessnewswire.comAIs Now The Time To Put Pro-Dex (NASDAQ:PDEX) On Your Watchlist?April 16, 2026 | finance.yahoo.comPro-Dex Completes Acquisition of Advanced Precision MachiningFebruary 12, 2026 | tipranks.comPro-Dex, Inc. Announces Acquisition of Advanced Precision MachiningFebruary 12, 2026 | accessnewswire.comAPro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month ResultsJanuary 29, 2026 | accessnewswire.comAWith 37% ownership, Pro-Dex, Inc. (NASDAQ:PDEX) has piqued the interest of hedge funds investorsJanuary 25, 2026 | uk.finance.yahoo.comPro-Dex: A Niche Surgical Tools Microcap Trading At A DiscountJanuary 17, 2026 | seekingalpha.comPro-Dex Valuation Is Attractive Despite Customer RiskJanuary 8, 2026 | seekingalpha.comPro-Dex stock surges after securing three-year contract extensionDecember 22, 2025 | za.investing.comPro-Dex, Inc. Announces Contract Extension With Largest CustomerDecember 19, 2025 | accessnewswire.comAInvestors Could Be Concerned With Pro-Dex's (NASDAQ:PDEX) Returns On CapitalDecember 13, 2025 | finance.yahoo.comLong Cast Advisers’ Updates on Pro-Dex (PDEX)December 1, 2025 | msn.comPro-Dex's (NASDAQ:PDEX) investors will be pleased with their notable 81% return over the last three yearsNovember 22, 2025 | finance.yahoo.comPro-Dex Reports Strong Earnings Growth in Q3 2025November 5, 2025 | tipranks.comPro-Dex (PDEX): One-Off Gain Drives Profit Margin Spike, Raising Questions on Earnings QualityNovember 1, 2025 | finance.yahoo.comPro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Top EstimatesOctober 30, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBDMD, PDEX, LUCD, and EMBC Company DescriptionsBaird Medical Investment NASDAQ:BDMD$1.28 0.00 (0.00%) Closing price 06/9/2026 04:00 PM EasternExtended Trading$1.27 -0.01 (-0.39%) As of 08:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.Embecta NASDAQ:EMBC$3.31 -0.03 (-0.90%) Closing price 06/9/2026 04:00 PM EasternExtended Trading$3.29 -0.02 (-0.60%) As of 08:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.Lucid Diagnostics NASDAQ:LUCD$0.99 +0.03 (+3.28%) Closing price 06/9/2026 04:00 PM EasternExtended Trading$1.01 +0.02 (+1.77%) As of 08:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.Pro-Dex NASDAQ:PDEX$65.00 0.00 (0.00%) Closing price 06/9/2026 04:00 PM EasternExtended Trading$64.85 -0.15 (-0.23%) As of 06/9/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Corning Is Paving AI's Future With Glass Optical Cable Corporation: Strong Earnings, But Hurdles Remain The J.M. Smucker Company’s Dividend: Too Sweet to Ignore? Why's Amazon Suddenly Lagging the S&P 500, and Is It a Warning? Apple's Siri AI Was Finally Announced, So Why Is the Stock Tanking? From Crypto to AI: Insiders Are Trading These 3 Stocks The Case for Intel Over Pure-Play Quantum Firms Has Temu-Owner PDD's Story Changed After Double Miss? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
